Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,460 across all filing types
Latest filing 2025-05-14 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
2024年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 Annual General Meeting (AGM) of 华邦生命健康股份有限公司. It includes voting results on various agenda items such as the 2024 board work report, supervisory board report, financial statements, profit distribution plan, appointment of auditors, amendments to company bylaws, and election of directors. The document also mentions the meeting date, attendance, voting methods, and legal opinions confirming the validity of the meeting and voting process. The content is focused on the AGM meeting decisions and voting outcomes rather than the full annual report or financial statements themselves. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (6236 characters) and detailed voting results support this classification with high confidence.
2025-05-14 Chinese
关于董事会换届完成及聘任高级管理人员、证券事务代表的公告
Board/Management Information Classification · 100% confidence The document is an announcement from 华邦生命健康股份有限公司 regarding the completion of the board of directors' re-election and the appointment of senior management and securities affairs representatives. It details the composition of the new board, committee memberships, and biographies of the directors and senior management. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes in the company's board and management personnel. Therefore, this document fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed information about board and management changes, confirming the classification.
2025-05-14 Chinese
关于全资子公司获得《药品注册证书》的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Huabang Life Health Co., Ltd. regarding its wholly-owned subsidiary receiving a drug registration certificate from the National Medical Products Administration. It details the drug's basic information, approval, and impact on the company. The document is short (938 characters) and serves as an official announcement of a regulatory approval event rather than a financial report or detailed corporate filing. It does not contain financial data, management changes, or voting results. It is not a report publication announcement since it does not mention any report being attached or published. The content fits best under a general regulatory announcement category.
2025-04-24 Chinese
关于非公开发行可交换公司债券发行完成的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (832 characters) about the completion of a non-public issuance of exchangeable corporate bonds by the company. It includes details such as bond name, issuance scale, term, and exchange period. It references prior announcements and regulatory approvals but does not contain comprehensive financial statements or detailed financial analysis. The document is an update on financing activity, specifically about bond issuance completion, which fits the Capital/Financing Update category. It is not a full financial report, earnings release, or regulatory filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-04-23 Chinese
估值提升计划
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about its 'Valuation Enhancement Plan' triggered by the stock price being below net asset value for 12 consecutive months, as per regulatory guidance. It includes strategic measures such as focusing on core business, improving profitability, cash dividends, share repurchase, M&A considerations, and investor relations. The document references board meeting approvals and regulatory compliance but does not contain financial statements or quarterly/yearly financial results. It is a corporate announcement about a strategic plan rather than a financial report or earnings release. The document length is 3430 characters, which is relatively short but contains substantive content about the plan itself, not just a notice of report publication. Therefore, it fits best under Capital/Financing Update (CAP) as it discusses share repurchase, dividends, and capital management strategies to enhance valuation.
2025-04-22 Chinese
市值管理制度（2025年4月）
Governance Information Classification · 95% confidence The document is titled '市值管理制度' which translates to 'Market Value Management System' and outlines the company's policies and procedures for managing its market value. It includes chapters on general principles, objectives, organizational responsibilities, management methods, monitoring and emergency measures, and supplementary provisions. The content is regulatory and governance-related, focusing on internal rules and compliance with laws and regulations. There is no financial data, earnings information, or report publication announcement. It is not a report of financial results, audit, or legal proceedings. The document fits best under Governance Information (CGR) as it details the company's internal governance practices related to market value management.
2025-04-22 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.